Sort
10,766 grants matching “checkpoint inhibitor”
Tumor cell metabolism in action
$501,299Eileen White · Rutgers Biomedical And Health Sciences · R01 · FY2024 · CA
Tumor Organoid-Mediated Drug Testing and Clonality Analysis in Peritoneal Surface Disease of Intestinal Origin
$501,170Konstantinos Votanopoulos · Wake Forest University Health Sciences · R01 · FY2021 · CA
Transcriptional Checkpoints Of Autoimmune Encephalomyelitis
$501,155Martha S Jordan · University Of Pennsylvania · R01 · FY2022 · AI
Transcriptional Checkpoints Of Autoimmune Encephalomyelitis
$501,155Martha S Jordan · University Of Pennsylvania · R01 · FY2024 · AI
Transcriptional Checkpoints Of Autoimmune Encephalomyelitis
$501,155Martha S Jordan · University Of Pennsylvania · R01 · FY2023 · AI
MODULATION OF CD5 SIGNALING TO ENHANCE ADOPTIVE T-CELL THERAPIES FOR CANCER
$501,149Marco Ruella · University Of Pennsylvania · R37 · FY2024 · CA
NETs: Protection or Harm in Neonatal Inflammation and Infection
$501,139Christian Con Yost · Utah State Higher Education System--University Of Utah · R01 · FY2025 · HD
Clinical translation of 19F MRI to visualize cancer immunotherapeutic cells
$501,116Eric T Ahrens · University Of California, San Diego · R01 · FY2020 · CA
Biochemical Studies of Human DNA Polymerase Delta
$501,002Marietta Y. Lee · New York Medical College · R01 · FY2006 · GM
Biochemical Studies of Human DNA Polymerase Delta
$500,824Marietta Y. Lee · New York Medical College · R01 · FY2007 · GM
Project 1: Delta immune Ecology of NSCLC
$500,733Alexander Robertson Allan Anderson · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2025 · CA
Project 1: Delta immune Ecology of NSCLC
$500,733Alexander Robertson Allan Anderson · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2023 · CA
Investigating the roles of extracellular cGAMP and harnessing it for cancer treatment
$500,645Aaron F Straight · Stanford University · R01 · FY2025 · CA
Drug Mechanism of Action-based targeting of tumor subpopulations
$500,354Andrea Califano · Columbia University Health Sciences · U54 · FY2025 · CA
Overcoming Therapy Resistance in SCLC
$500,308Esra Akbay · Ut Southwestern Medical Center · R01 · FY2024 · CA
Targeting ATM to boost systemic effects of radiotherapy and immunotherapy
$500,236Yunyan Jennifer Jennifer Zhang · Duke University · R01 · FY2024 · CA
Leveraging Novel Randomized Clinical Trials of Vitamin D Supplementation in Patients with Colorectal Cancer: Impact on Survival and Anti-Tumor Immunity
$500,170Kimmie Ng · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Leveraging Novel Randomized Clinical Trials of Vitamin D Supplementation in Patients with Colorectal Cancer: Impact on Survival and Anti-Tumor Immunity
$500,043Kimmie Ng · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Mayo Clinic Breast Cancer SPORE
$500,000James Newell Ingle · Mayo Clinic Rochester · P50 · FY2010 · CA
Mechanisms of PD-1 and Tim-3 crosstalk in tumor-infiltrating lymphocytes
$499,975Robert L Ferris · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA
Exploring the Function of MHC-II/Lag3 Axis in Brain Metastasis to Develop Novel Therapeutic Strategies
$499,828Dihua Yu · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Cyclin C-CDK8/19 kinases in development and in cancer
$499,671Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2024 · CA
An integrated polymeric carrier for subunit cancer vaccines
$499,661Suzie H Pun · University Of Washington · R01 · FY2024 · CA
Exploring novel therapeutic strategies for combinatory therapy to treat renal clear cell carcinomas
$499,609Weizhou Zhang · University Of Florida · R01 · FY2025 · CA
Project 3
$499,545Dimitrios P Kontoyiannis · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · P01 · FY2025 · AI